A carregar...
Development of a Neuroprotective Erythropoietin Modified with a Novel Carrier for the Blood–Brain Barrier
Extremely high doses of erythropoietin (EPO) has been used for neuroprotection in ischemia–reperfusion brain injury to deliver sufficient amounts of EPO across the blood–brain barrier (BBB); however, harmful outcomes were observed afterward. We aimed to test the ability of HBHAc (heparin-binding hae...
Na minha lista:
| Publicado no: | Neurotherapeutics |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609523/ https://ncbi.nlm.nih.gov/pubmed/32144722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00845-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|